 |
|
Liposomal SunActive versus conventional iron for treatment of iron-deficiency anemia in children aged 2–12 years: a prospective randomized controlled trial
Wael A. Bahbah, Yasmin A.H.S. Younis, Hanan Salama Elbelouny, Asmaa A. Mahmoud
Clin Exp Pediatr. 2025;68(8):608-615. Published online 2025 Jul 18 DOI: https://doi.org/10.3345/cep.2025.00262
|
|
Citations to this article as recorded by
 Liposomal iron in under-5 iron-deficiency anemia: efficacy signals, but implementation needs“dose–context” calibration
M. Vijayasimha, M. Srikanth
Indian Journal of Hematology and Blood Transfusion.2026;[Epub] CrossRef Oral liposomal iron vs. oral iron polymaltose in children with chronic kidney disease iron deficiency anemia: a cross-over study
Happy Sawires, Eman Abobakr Abd Alazem, Fatma Atia, Amr Salem, Amira Samy, Mohamed Gamal
Pediatric Nephrology.2026; 41(6): 1803. CrossRef Pediatric Oral Iron Therapy: Choosing the Right Product for Your Patient
Sonia Alexiadou, Emmanouela Tsouvala, Elpis Mantadakis
Hematology Reports.2026; 18(2): 20. CrossRef Thrombosis and Anemia in Pediatric Inflammatory Bowel Disease: Pathophysiology, Clinical Impact and Future Directions
Dragos-Florin Tesoi, Monica Hancianu, Laura Mihaela Trandafir, Manuela Ciocoiu, Maria Cristina Vladeanu, Larisa-Ioana Barbosu, Laura Bozomitu, Otilia Elena Frasinariu, Iris Bararu-Bojan, Oana-Viola Badulescu
International Journal of Molecular Sciences.2025; 26(21): 10407. CrossRef
|